Does RILUZOLE Cause Salivary hypersecretion? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Salivary hypersecretion have been filed in association with RILUZOLE (Teglutik). This represents 0.5% of all adverse event reports for RILUZOLE.
7
Reports of Salivary hypersecretion with RILUZOLE
0.5%
of all RILUZOLE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Salivary hypersecretion From RILUZOLE?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILUZOLE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RILUZOLE Cause?
Death (238)
Nausea (111)
Diarrhoea (94)
Dizziness (60)
Drug ineffective (58)
Disease progression (57)
Fatigue (56)
Off label use (52)
Abdominal discomfort (50)
Hypoaesthesia oral (50)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which RILUZOLE Alternatives Have Lower Salivary hypersecretion Risk?
RILUZOLE vs RIMABOTULINUMTOXINB
RILUZOLE vs RIMEGEPANT
RILUZOLE vs RIOCIGUAT
RILUZOLE vs RIPRETINIB
RILUZOLE vs RISANKIZUMAB